Picton Mahoney Asset Management’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Picton Mahoney Asset Management’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$1K	–	711
2022 Q4	$1K	Hold	100,000	–	–	﹤0.01%	671
2022 Q3	$10K	Hold	100,000	–	–	﹤0.01%	635
2022 Q2	$8K	Hold	100,000	–	–	﹤0.01%	782
2022 Q1	$20K	Hold	100,000	–	–	﹤0.01%	835
2021 Q4	$55K	Hold	100,000	–	–	﹤0.01%	784
2021 Q3	$60K	Hold	100,000	–	–	﹤0.01%	693
2021 Q2	$76K	Buy	+100,000	New	+$60.7K	﹤0.01%	724

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Picton Mahoney Asset Management's IBER.WS Position: Q1 2023 in Review

Picton Mahoney Asset Management sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 100,000 shares — an estimated $1K sold.

Picton Mahoney Asset Management first reported a position in IBER.WS in Q2 2021 and held it in 7 quarters. The position peaked at $76K in Q2 2021. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Picton Mahoney Asset Management reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 100,000 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $1K.
Picton Mahoney Asset Management first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q2 2021 and held it in 7 quarters.
Picton Mahoney Asset Management's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $76K in Q2 2021.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2023, filed 8 May 2023.